Position in RYTM
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,049,122
+$240,562 QoQ
Shares Held
9,449
+1.6% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#160
of 299 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AlphaCentric Advisors LLC holds $32,614,824 across 48 Biotechnology names. RYTM ranks #11 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,002 | $2,484,643 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
48,355 | $1,711,283 | |
| 3 | ARGX |
Argenx SE
|
1,806 | $1,675,552 | |
| 4 | INCY |
Incyte Corp
|
14,451 | $1,638,165 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
6,531 | $1,598,592 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
11,533 | $1,530,775 | |
| 7 | INSM |
INSMED Inc
|
11,699 | $1,247,347 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
15,430 | $1,223,444 |
All Filings in RYTM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,049,122 | 9,449 | Shares | Other | 2026-07-24 | |
| 2026-03-31 | $808,560 | 9,297 | Shares | Other | 2026-05-07 | |
| 2025-12-31 | $540,766 | 5,052 | Shares | Other | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||